Kiromic Biopharma Inc
Change company Symbol lookup
Select an option...
KRBP Kiromic Biopharma Inc
CYPS Cyclo3pss Corp
CXW CoreCivic Inc
STM STMicroelectronics NV
NYT New York Times Co
SOS Sos Ltd
DDOC DERMADOCTOR, INC.
CLOV Clover Health Investments Corp
POL Polished.Com Inc
ENJYQ Legacy EJY Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |
Company profile

Kiromic BioPharma, Inc. is an artificial intelligence (AI) driven, end-to-end allogenic cell therapy company. The Company is engaged in developing the multi-indication allogeneic T cell therapy that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The Procel, Isocel, and Deltacel product platform candidates consist of allogeneic cell therapy candidates that are in the preclinical development stage. Its Procel product candidate consists of engineered GDTs targeting PD-L1. Its Isocel product candidate consists of engineered GDTs targeting Mesothelin Isoform 2 positive tumors (Iso-Meso). Its Deltacel product candidate consists of non-engineered GDTs used to treat solid tumors. Its Allogenic Lead Exogenous Isoforms (ALEXIS)-PRO-1 trial candidate is its allogeneic GDT therapy product targeting PD-L1. Its ALEXIS-ISO-1 trial candidate is its allogenic GDT therapy product targeting an isoform of Mesothelin that is present in tumor cells, namely Isomeso.

Closing Price
$0.2614
Day's Change
-0.0026 (-0.98%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.2699
Day's Low
0.25
Volume
(Heavy Day)
Volume:
121,222

10-day average volume:
59,442
121,222
  • Prev Close
    0.264
  • Today's Open
    0.2508
  • Day's Range
    0.25-0.2699
  • Avg Vol (10-day)
    59.4K
  • Last (time)
    3:35p ET 12/02/22
  • Last (size)
    9
  • 52-Wk Range
    0.23 - 2.51
    LowHigh
  • (12/02/21 - 05/24/22)
    13.65%
  • 152.3%
  • Market Cap
    4.8M
  • Shares Outstanding
    18.2M
  • -2.11
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 4.99
  • (% of float 11/15/22)
    3.71

Latest News

November 08, 2022
9:30 am ET
PR Newswire
October 27, 2022
8:48 am ET
BusinessWire
October 06, 2022
8:08 am ET
BusinessWire
October 04, 2022
9:00 pm ET
Accesswire
5:45 pm ET
Accesswire
2:42 pm ET
Newsfile
12:59 pm ET
Newsfile
12:29 pm ET
Globe Newswire
11:36 am ET
PR Newswire
10:30 am ET
Accesswire
10:01 am ET
Newsfile
9:51 am ET
Newsfile
5:45 am ET
PR Newswire
October 03, 2022
8:00 pm ET
Accesswire
6:15 pm ET
Accesswire
5:39 pm ET
Newsfile
1:01 pm ET
Newsfile
11:32 am ET
Accesswire
11:00 am ET
BusinessWire
10:45 am ET
PR Newswire
10:35 am ET
Newsfile
9:45 am ET
Newsfile
9:15 am ET
Globe Newswire
5:45 am ET
PR Newswire
October 02, 2022
9:00 pm ET
Globe Newswire
12:01 pm ET
PR Newswire
10:16 am ET
Globe Newswire
8:52 am ET
Newsfile
October 01, 2022
1:14 pm ET
Newsfile
1:12 pm ET
Accesswire
10:00 am ET
Accesswire
September 30, 2022
9:00 pm ET
BusinessWire
6:02 pm ET
Newsfile
3:07 pm ET
PR Newswire
1:06 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.